TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,148,383
|
2,224,055
|
982,868 |
| Earnings before taxes |
66,129
|
50,648
|
29,919 |
| Total assets |
539,402
|
1,103,206
|
475,417 |
| Current assets |
515,673
|
531,572
|
475,122 |
| Current liabilities |
326,499
|
308,315
|
278,969 |
| Equity capital |
210,522
|
692,400
|
192,443 |
| - share capital |
6,033
|
5,662
|
5,365 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.0%
|
62.8%
|
40.5% |
| Turnover per employee |
7,656
|
14,827
|
6,552 |
| Profit as a percentage of turnover |
5.8%
|
2.3%
|
3.0% |
| Return on assets (ROA) | |||
| Current ratio |
157.9%
|
172.4%
|
170.3% |
| Return on equity (ROE) |
31.4%
|
7.3%
|
15.5% |
| Change turnover |
-1,221,281
|
1,186,700
|
41,553 |
| Change turnover % |
-52%
|
114%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.